AESTURA, Amorepacific's authentic derma brand, has been named Korea's No. 1 selling dermocosmetics skincare brand1 according to findings by global market intelligence firm Euromonitor International.
Grounded in its derma heritage originating from Pacific Pharma in 1982 and Amorepacific's research expertise, AESTURA has established itself as Korea's leading authentic K-Derma brand. Starting with the launch of dermatological cosmetics through hospital channels in 2008 and introducing the ATOBARRIER365 Cream at Olive Young in 2018, the brand expanded its customer touchpoints based on proven product efficacy, pioneering the commercialization of derma cosmetics.
AESTURA's flagship product, ATOBARRIER365 Cream, is the best-selling item that drove the brand's growth. Consistently favored as a barrier moisturizing care solution for sensitive skin, it has recorded impressive sales figures, with one unit currently sold every five seconds.2 It also demonstrated its market competitiveness by winning first place in the Olive Young Awards' Cream category for two consecutive years.
Building on its domestic growth momentum, AESTURA is accelerating its expansion into global markets. Following key Asian markets such as Japan, Vietnam, and Thailand, the brand launched at Sephora in the United States last year and expanded its sales channels to Canada, Australia, China, and major European markets this year. At Sephora in Europe, it is swiftly expanding its consumer touchpoints, featuring products in approximately 860 stores across 19 countries.
An AESTURA representative said, "It is meaningful that AESTURA has been recognized as Korea's leading derma skincare brand through this Euromonitor ranking. We will continue to make our proven sensitive skin solutions more accessible across the globe and grow into a world-class derma brand."
1 Beauty and Personal Care 2026 Edition, Dermocosmetics Skincare category, based on retail sales value across all retail channels in 2025.
2 Based on domestic and global sales volume of ATOBARRIER365 Cream (January 2026–June 2026)